Telehealth Based Synchronous Navigation to Improve Molecularly-Informed Care for Patients With Lung Cancer
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir)
- Status
- TERMINATED
- Phase
- PHASE1
A Study of CDX-585 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Lazertinib+Pemetrexed/Carboplatin in Patients With EGFR Sensitizing Mutation Positive Recurrent or Metastatic Non-Small Cell Lung Cancer Failed to Prior Lazertinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Examination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study Experiences
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC (ECTOP-1013)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of RO7515629 in Participants With HLA-G Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Prevalence of HER3 Expression in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of TAS3351 in NSCLC Patients With EGFRmt
- Status
- TERMINATED
- Phase
- PHASE1
Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients
- Status
- RECRUITING
- Phase
- PHASE2
Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Study of Ametinib Combined With Bevacizumab in First-line Treatment of Advanced NSCLC With EGFR-mutations.
- Status
- RECRUITING
- Phase
- PHASE2